Drugs / Celstem®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04749758 | Sep 2018 → Dec 2022 | osteoarthritis, knee | University of Andorra | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Celstem | “SVF treatment is developed by Cellab Laboratory (Celstem®).” NCT04749758 ↗ |
| Known as | SVF treatment | “SVF treatment is developed by Cellab Laboratory (Celstem®).” NCT04749758 ↗ |
| Modality | Cell therapy | “A concentrated cell suspension in a reduced volume is obtained.” NCT04749758 ↗ |
| Route | Other | “Under sterility measures, intraarticular infiltration of SVF treatment (Celstem®) is performed at affected knee or knees.” NCT04749758 ↗ |